Ashutosh Tewari, MBBS, MCh, FRCS (Hon)
- PROFESSOR AND SYSTEM CHAIR | Urology
- PROFESSOR | Oncological Sciences
Specialty:
Urology
Ashutosh (Ash) K. Tewari, MD, Chairman, Milton and Carroll Petrie Department of Urology at the Icahn School of Medicine at Mount Sinai is a world-renowned urologist and prostate cancer specialist. As Director of the Department of Urology, he leads a multidisciplinary team committed to improving prostate cancer treatment, research, and education. To date, he has performed over 5,000 robotic radical prostatectomy surgeries. The Tewari Lab is working on unlocking the genomic causes of prostate cancer and translating genomic information to practical physician application through imaging. In 2012, he was awarded the American Urological Association’s Gold Cystoscope Award. This honor is given annually to the urologist who has contributed significantly to the field within 10 years of completing residency. Dr. Tewari holds several leadership positions domestically and internationally.
Dr. Tewari received his undergraduate and medical degrees at GSVM Medical College (Kanpur, India). During medical school he was awarded 17 Gold Medals for outstanding performance on university exams. Dr. Tewari completed his first urology residency at Sanjay Gandhi Post Graduate Institute of Medical Sciences (Lucknow, India). He completed fellowships in urologic-oncology at University of California, San Francisco and the University of Florida (Gainesville, FL). In 2004, he completed his second urology residency at Henry Ford Hospital (Detroit, Michigan). While at Henry Ford, Dr. Tewari was part of the team that performed the first robotic radical prostatectomy in the United States.
Clinical Care
Dr. Tewari’s case series is one of the largest in the world and his outcomes are considered the gold standard for this procedure. Dr. Tewari’s clinical expertise in prostate cancer includes targeted biopsies, cystoscopies, robotic prostatectomies, as well as the management of active surveillance prostate cancer patients. He has also initiated clinical protocols investigating the utility of focal therapy platforms for the treatment of prostate cancer. Dr. Tewari has been consecutively listed in New York Magazine’s Top Doctors issue since 2006. Learn more at his Center for Prostate Cancer at http://www.prostatecancercenternyc.com.
Research
Dr. Tewari’s research approaches the problem of prostate cancer from distinct perspectives.
His outcomes research group is investigating the epidemiological effects of prostate cancer. He is also investigating several novel imaging techniques for identifying prostate cancer imaging biomarkers. Dr. Tewari is also working to unlock the genomic causes of prostate cancer.
As a researcher, Dr. Tewari has authored over 250 peer-reviewed articles, book chapters, and textbooks on prostate cancer and robotic surgery. This includes several high-impact articles in Nature, Cell, and PNAS. Most recently he has edited Prostate Cancer: A Comprehensive Perspective (Elsevier 2013).
In addition to his publications, Dr. Tewari is the recipient of three major NIH Federal Research Awards. This includes an R01 grant, in which he serves as Principal Investigator, investigating the utility of multiphoton microscopy during prostate cancer treatment. Dr. Tewari also serves as site-PI for the NIH/NCI The Cancer Genome Atlas Tissue Source Site and the NIH/NCI Early Detection Research Network. In addition to his federal funding, Dr. Tewari is currently funded by the Prostate Cancer Foundation, Boston Scientific, and Medtronic. He has initiated collaborative work with several other leading institutions including Cold Spring Harbor Laboratory, the Broad Institute of MIT and Harvard, The Koch Institute for Integrative Cancer Research at MIT, Dana-Farber Cancer Institute, and Rockefeller University,
Training
Dr. Tewari has trained over 30 fellows and residents in robotics. His fellows have gone on to establish successful prostate cancer programs in Canada, Great Britain, India, Japan, and Singapore. Dr. Tewari hosts an annual international prostate cancer symposium. Each year nearly 1000 attendees attend this symposium to discuss the latest breakthroughs and emerging topics in prostate cancer treatment and research. The proceedings of this meeting are covered by European Urology (the urology journal with the highest impact factor).
Patient Stories
https://www.mountsinai.org/about/patient-stories/all-in-the-family
https://www.mountsinai.org/about/patient-stories/speaking-up-for-others-and-himself
Current Affiliations
Dr. Tewari is affiliated with over 40 professional associations and organizations, including:
-Member, American Urological Association
-Member, Society of Minimally Invasive Surgery
-Member, Society of Robotic Surgery (SRS)
-Member, Society of Urologic Oncology (SUO)
-Fellow, New York Academy of Medicine
-Associate Editor, AUA News
-Associate Editor, BJUI
-Reviewer, Journal of Urology
-Reviewer, European Urology
Certifications
American Board of Urology
Clinical Focus
- Cystoscopy
- Laparoscopy
- Prostate Biopsy
- Prostate Cancer
- Prostate Cancer Screening
- Prostate-Specific Antigen (PSA) Test
- Prostatectomy
- Robotic Prostate Surgery
Multi-Disciplinary Training Area
Cancer Biology [CAB]Education
MBBS, G.S.V.M. Medical College
Internship, Surgery, GSVM Medical College, Kanpur Univ.
Residency, Surgery, G.S.V.M. Medical College
Residency, Urology, Henry Ford Hospital
Fellowship, Transplant, University of Liverpool
Fellowship, Urology Oncology, University of Florida
Fellowship, Urology Oncology, Henry Ford Hospital
-
2012
Gold Cytoscope Award -
2012
Most Compassionate Doctor Award -
2012
First Prize Best Abstract -
2011
Yahya Cohen Memorial Lecture and Medal -
2011
American Society of Clinical Oncology Merit Award -
2009
Syme Medal -
2009
BJU International Visiting Professor Award -
2008
Grand Prize -
2007
America's Best Doctors
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Tewari during 2022 and/or 2023. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Company Founder:
- Prostate Cancer Foundation (PCF)
Consulting:
- Oncovir, Inc.; Vir Biotechnology
Equity (Stock or stock options valued at greater than 5% ownership of a publicly traded company or equity of any value in a privately held company)
- Promaxo
Industry-Sponsored Lectures: MSSM faculty occasionally give lectures at events sponsored by industry, but only if the events are free of any marketing purpose.
- Intuitive Surgical, Inc.
Other Activities: Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership.
- Axogen; Bayer HealthCare Pharmecauticals Inc.; Blue Earth Diagnostics Ltd.; Dendreon Corporation; Global Prostate Cancer Research Foundation (PCF); Intuitive Surgical, Inc.; Janssen Research and Development, LLC; Kalyani Prostate Cancer Institute; Kite Pharma; Lumicell, Inc; Promaxo; Promaxo (Stock); Prostate Cancer Foundation (PCF); RhoVac ApS.; Roivant
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.